Intel Corporation stays a Buy after strong Q2 results and SK hynix partnership talks. Click for this updated look at INTC and ...

Mammoth Energy (TUSK) shifts to a miniconglomerate to cut oilfield cyclicality—yet remains highly speculative.

NNN REIT earns a Strong Buy: 6% yield, low 11.7x P/FFO, 99.1% occupancy, raised AFFO guidance, and dividend growth—read now ...

Mueller Water Products, Inc. outlook: resilient municipal demand, data center/AI valve growth, and margin expansion. Click ...

Explore what’s driving recent Treasury yield volatility, what could move rates next, and why a bond crisis may be coming—plus ...

Meta Platforms, Inc.: why it’s still a Strong Buy despite legal charges and higher costs—new AI and subscription revenue ...

AI tailwinds and robust profitability support the investment thesis, making the current valuation appear especially ...

SCHD remains a core dividend ETF buy: low-cost, recession-resistant tilt (healthcare/staples) and 2026 outperformance outlook ...

DNOW is rated Hold with a $14 price target, reflecting improved sales post-MRC Global merger but pressured gross margins.

SELLAS Life Sciences is rated Hold, with a $9.25 price target, as current valuation already reflects high REGAL trial success ...

Advanced Micro Devices is a Hold, favoring dip-buying near $425 over chasing momentum at current levels given execution and ...

Invesco US Growth Team’s constructive outlook for US equities is supported by resilient economy, strong corporate profits, ...